This antibody-drug Ozogamicin represents a important advance in the therapy of relapsed leukemic disease, specifically relapsed blood leukemia (AML). This particular conjugate links a monoclonal molecule directed for https://bookmark-template.com/story28591288/this-antibody-drug-the-conjugate-a-comprehensive-analysis